Long‐term antiarrhythmic therapy with N‐acetylprocainamide
- 1 March 1979
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 25 (3), 273-282
- https://doi.org/10.1002/cpt1979253273
Abstract
The effects of long-term NAPA therapy were evaluated in 6 patients with chronic PVCs known to respond to this drug during a previous placebo-controlled, dose-ranging trial. Underlying cardiac status was evaluated every six months by switching each patient from NAPA to placebo. Placebo period PVC frequency after one year of NAPA therapy was reduced, compared to baseline placebo values. Mean PEP/LVET, measured while the patients received placebo, was elevated at the beginning of the study but was normal after one year of NAPA therapy. Comparison of NAPA and placebo period observations indicated a reduction in PEP/LVET when NAPA therapy was begun. This effect, however, could not be demonstrated one year later when mean placebo period PEP/LVET was normal. The apparent dependence of this effect on underlying status of left ventricular function suggests that the initial reduction in PEP/LVET represents an indirect effect of NAPA rather than a direct inotropic action. NAPA therapy was well tolerated by the 6 patients and ANA titers became abnormal in only one, in marked contrast to reported experience with procainamide.This publication has 6 references indexed in Scilit:
- Procainamide and N‐acetylprocainamide kinetics investigated simultaneously with stable isotope methodologyClinical Pharmacology & Therapeutics, 1977
- Vasodilator Therapy of Cardiac FailureNew England Journal of Medicine, 1977
- Vasodilator Therapy of Cardiac FailureNew England Journal of Medicine, 1977
- Determination of plasma procainamide and N-acetylprocainamide concentration by high-pressure liquid chromatography.Clinical Chemistry, 1977
- Dose‐ranging trial of N‐acetylprocainamide in patients with premature ventricular contractionsClinical Pharmacology & Therapeutics, 1977
- Antiarrhythmic efficacy of N‐acetylprocainamide in patients with premature ventricular contractionsClinical Pharmacology & Therapeutics, 1976